- Service Name
Massive Bio
- Industry
Healthcare, Oncology, Clinical Trials, Patient Support
- Main Value Proposition
Massive Bio offers a streamlined process for cancer patients to find and enroll in clinical trials, ensuring they receive the best possible care and support.
- Description
Massive Bio is an AI-powered platform that connects cancer patients with clinical trials tailored to their specific needs. It aims to enhance the patient experience by providing quick access to relevant clinical trials worldwide.
- Key Features
AI-powered precision matching for cancer trials; Instant prequalification based on medical history; Personalized report within 24 hours; Support throughout the clinical trial journey
- Use Cases
Massive Bio is most valuable for cancer patients seeking clinical trials, physicians looking to refer patients, and caregivers assisting patients in navigating trial options.
- Competitive advantages
Extensive database of over 19,000 cancer trials; Personalized support and financial assistance options; Quick and easy access to trial information for both patients and physicians
- Strengths
The service excels in its AI-driven matching capabilities, comprehensive support for patients, and a user-friendly interface that simplifies the clinical trial process.
- Positioning
Massive Bio positions itself as a leader in the oncology sector, focusing on innovative technology to improve patient access to clinical trials.
- Audience
The primary target users include cancer patients, healthcare providers (physicians), and caregivers who are involved in the treatment journey.
- CTA
Get Started Now
- Tags
AI-powered platform
cancer trials
clinical trial matching
patient support
- Tagline
Find the right cancer trials
- Tone of Voice
Empathetic, informative, supportive
- Differentiation
Massive Bio uniquely combines AI technology with the expertise of real physicians to provide accurate trial matches based on individual medical conditions and genomic profiles.
- Brand Positioning
The brand identity emphasizes trust, innovation, and a commitment to improving cancer care through technology and personalized support.
- Founded
2015-05-04
- Founders
Arturo Loaiza-Bonilla
Cagatay Culcuoglu
Selin Kurnaz